Heska Corp represents values of innovation, integrity, and commitment in the veterinary diagnostic and specialty products industry. The company is dedicated to providing advanced and reliable solutions that improve animal health and the veterinary experience. With a corporate philosophy centered on delivering quality products and exceptional customer service, Heska Corp strives to make a positive impact on the veterinary community and ultimately contribute to the well-being of animals worldwide.

Heska Corp is primarily present in the United States and around the globe. With its headquarters situated in Loveland, Colorado, the company has a strong presence in the domestic market. Additionally, Heska Corp has expanded its reach to various international markets, catering to the needs of veterinarians and animal healthcare providers worldwide. With its innovative and high-quality veterinary products and solutions, Heska Corp has gained recognition in countries and regions across North America, Europe, Asia, and Latin America. As a leading player in the veterinary diagnostics and specialty products industry, Heska Corp continues to serve its customers globally with its extensive network and strategic partnerships.

Heska Corp has achieved several significant milestones throughout its history. One notable milestone was in 2001, when Heska became a publicly traded company on the NASDAQ stock exchange, marking a major step in its growth and development. Additionally, in 2015, Heska Corp introduced the Element COAG Veterinary Hemostasis Analyzer, a groundbreaking diagnostic instrument that revolutionized coagulation testing in veterinary medicine. Furthermore, in 2018, Heska acquired CVM Diagnostico Veterinario, a leading veterinary diagnostic company in Latin America, expanding its global presence and market reach. These milestones demonstrate Heska Corp's commitment to innovation, expansion, and providing advanced diagnostic solutions for the veterinary industry.

Heska Corp is a leading animal health company founded in 1988. With headquarters in Loveland, Colorado, it has become a prominent player in veterinary diagnostics, vaccines, and specialty products. Heska Corp operates in four main segments: Core Companion Animal Health, including point-of-care diagnostic instruments; Other Vaccines and Pharmaceuticals, providing pharmaceuticals and vaccines for pets; North American Production Animal, focusing on advanced solutions for livestock management; and International, catering to veterinary needs worldwide. Heska Corp's commitment to innovation and quality has earned it a solid reputation in the veterinary industry, making it a trusted partner for pet owners, veterinarians, and livestock producers globally.

The main competitors of Heska Corp in the market include IDEXX Laboratories, Abaxis Inc., and Zoetis Inc. These companies operate in the animal health and veterinary diagnostics sector, similar to Heska Corp. IDEXX Laboratories is a key competitor known for its broad range of diagnostic products and services. Abaxis Inc., now a part of Zoetis Inc., also offers a variety of diagnostic instruments and consumables for animal healthcare. These competitors challenge Heska Corp by providing alternative solutions and vying for market share in the veterinary diagnostics industry.

Heska Corp is primarily active in the animal health industry.

The business model of Heska Corp revolves around providing advanced veterinary diagnostic and specialty products. Heska specializes in developing and manufacturing veterinary laboratory instruments, consumables, and software solutions. The company aims to improve pet care by offering innovative point-of-care diagnostics, digital imaging tools, and specialized tests to veterinary professionals worldwide. Heska's products enable veterinarians to make faster and more accurate diagnoses, resulting in improved treatment and care for animals. With its commitment to technological advancements and focus on veterinary diagnostics, Heska Corp strives to enhance the overall well-being of pets and strengthen the veterinary industry.

Heska에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

Heska에 대한 현재 KUV는 계산할 수 없습니다.

Heska에 대한 AlleAktien 품질 점수는 4/10입니다.

Heska에 대한 현재 매출은 계산할 수 없습니다.

Heska의 현재 이익을 계산할 수 없습니다.

The Heska Corporation is a leading company in the animal health industry, offering innovative diagnostic and therapeutic solutions to veterinarians and pet owners. The company, headquartered in Loveland, Colorado, was founded in 1988 and now has subsidiaries in the USA, Europe, and Asia. Heska offers a wide range of products and services for animal health, divided into three divisions: 1. Diagnostics: Heska's diagnostics division provides veterinarians with a wide range of tests, instruments, and systems for diagnosing diseases in animals. The product range includes simple rapid tests for routine examinations to specialized devices for complex diagnoses. Products include blood tests for dogs and cats, in-house diagnostic devices, analyzers for laboratory testing, and diagnostic systems for infectious diseases. 2. Scientific research: Heska has a strong presence in scientific research, particularly in immunology and oncology. The company offers a wide range of research products and services, including antibodies, enzymes, kits, and test systems for in vitro research. Heska has long-standing partnerships with renowned scientists and institutes around the world. 3. Therapeutics: Heska's therapeutics division focuses on the development and marketing of drugs and therapies for animals. The company has a wide range of products on the market, including pain relievers, antibiotics, and immunomodulators. Heska works closely with veterinarians and pet owners to ensure that its products meet the needs of animals and are effective. Heska is committed to offering innovative solutions for animal health and investing continuously in research and development. The company has a strong presence in the market and is known for its high-quality products and services. Heska also has a strong online presence and offers training and support for veterinarians and pet owners through its web portal. In summary, Heska offers a wide range of products and services for animal health. The company specializes in diagnostics, research, and therapeutics and is known for its high quality and innovation. Heska is committed to improving the health and well-being of animals worldwide and works closely with veterinarians and pet owners to ensure that its products meet the needs of animals.

Heska은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Heska의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Heska의 ISIN은 US42805E3062입니다.

Heska의 WKN은 A1H5J3입니다.

Heska의 티커는 HSKA입니다.

지난 12개월 동안 Heska은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Heska은(는) 0.2 USD의 배당금을 지급할 것으로 예상됩니다.

Heska의 현재 배당 수익률은 입니다.

Heska은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Heska은(는) 지난 5년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0.2 USD의 배당금이 예상됩니다. 이는 배당수익률 0.17 %에 해당합니다.

Heska은 '건강' 섹터에 속합니다.

Heska의 마지막 배당금을 0.1 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Heska는 0 USD를 배당금으로 지급했습니다.

Heska의 배당금은 USD에 지급됩니다.